From Molecules to Medicine: How Patients Can Share Their Voices Throughout The Drug Development Process
February 3, 2021
Related
NICE Recommends PTC’s AADC Gene Therapy
Rare Daily Staff The United Kingdom’s National Institute for Health and Care Excellence, the drug price watchdog, […]
Read more2023 RARE Mental Health Grant Recipients Announced
Global Genes is pleased to announce the Rare Disease Patient Advocacy Organizations receiving 2023 RARE Mental Health […]
Read moreSeeking a Sustainable Business Developing on N-of-1 Therapies
The ability to pinpoint the underlying genetic causes of diseases and rapidly generate genetic medicines to address […]
Read moreGlobal Genes Team Shares Their Stories on World Rare Disease Day
My daughter Juno was diagnosed with a very rare, severe neurodevelopmental condition called STXBP1-related disorder six years […]
Read moreRARE Global Advocacy Alliance Member Spotlight: Geoffrey Gee
Read moreFinding Me Through This Rare Journey
Patient or Advocate: Brittany Anderson Disease Affiliation: Fibrous Dysplasia, McCune Albright Syndrome, Panhypopituitarism, Adrenal Insufficiency, Trigeminal Neuralgia, […]
Read moreBorn to be rare, born to fight for tomorrow
Patient or Advocate: Nick Irwin Disease Affiliation: Porencephaly Hi. My name is Nick. I’m 6 foot 3 […]
Read moreWhat I Learned About Intrahepatic Cholestasis With Both of My Pregnancies
I frequently wake up thinking of how lucky we were. Before my first pregnancy, I have never […]
Read more